Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
STXS
#3668
Stereotaxis, Inc. Common Stock
2.020
0
USD
+4.39%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+4.39%
Mudança mensal
+4.68%
Mudança em 6 meses
-2.88%
Mudança anual
-2.88%
Fechamento anterior
1.935
0
Abrir
2.010
0
Bid
Ask
Mínimo
2.000
0
High
2.040
0
Volume
143
Mercados
Ações
Cuidados de saúde
STXS
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.76 M
74.64 M
75.05 M
82.13 M
85.98 M
97.25 M
—
Valuation ratios
Enterprise value
333.66 M
424.02 M
149.02 M
133.76 M
183.82 M
210.25 M
815.97 M
Price to earnings ratio
-46.27
-38.75
-8.08
-6.93
-7.6
-9.2
-33.29
Price to sales ratio
13.87
13.38
5.58
5.42
7.03
6.37
26.44
Price to cash flow ratio
-105.44
-159.02
-18.98
-16.51
-22.86
-15.29
-89.16
Price to book ratio
10.7
13.85
6.06
9.23
31.94
15.52
45.41
Enterprise value to EBITDA ratio
-51.34
-33.62
-8.28
-6.55
-7.97
-10.47
-37.78
Profitability ratios
Return on assets %
-0.12
-0.18
-0.34
-0.49
-0.51
-0.41
-0.47
Return on equity %
-0.19
-0.32
-0.69
-1.27
-3.95
-1.61
-6.09
Return on invested capital %
-227.69
-373.1
-434.78
-508.83
-402.05
-263.14
—
Gross margin %
71.04
66.36
64.51
53.32
52.85
51.98
208.46
Operating margin %
-25.15
-36.81
-65.58
-78.37
-89.6
-67.32
-273.94
EBITDA margin %
-24.42
-36.54
-62.84
-73.33
-83.57
-61.17
-232.91
Net margin %
-24.9
-30.61
-63.89
-74.33
-87.08
-65.9
-268.27
Liquidity ratios
Quick ratio
3.64
3.54
2.47
1.88
0.84
1.09
3.15
Current ratio
3.88
3.87
3.03
2.51
1.22
1.51
4.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.54
0.6
0.5
0.58
0.62
0.66
0.72
Solvency ratios
Debt to assets ratio
0.04
0
—
—
—
—
—
Debt to equity ratio
0.06
0
—
—
—
—
—
Long term debt to total assets ratio
0.02
0
—
—
—
—
—
Long term debt to total equity ratio
0.03
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.05
-0.04
-0.11
-0.11
-0.1
-0.15
-0.15
EBIT per share
-0.09
-0.17
-0.24
-0.26
-0.28
-0.24
-0.24
EBITDA per share
-0.09
-0.17
-0.24
-0.25
-0.27
-0.22
-0.21
Total debt per share
0.03
0
—
—
—
—
—
Cash per share
0.6
0.51
0.37
0.25
0.14
0.15
0.46
Net current asset value per share
0.72
0.68
0.57
0.41
0.31
0.37
1.21
Tangible book value per share
0.48
0.45
0.35
0.2
-0.06
0.04
-0.21
Working capital per share
0.54
0.5
0.38
0.25
0.06
0.13
0.23
Book value per share
0.48
0.45
0.35
0.2
0.07
0.15
0.27
Notícias
Shield Therapeutics registra crescimento de receita de 56% e se torna positiva em caixa
Citizens eleva perspectiva para ações da Stereotaxis com expansão de cateteres
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Lucro da Stereotaxis veio em linha com as projeções; receita menor do que estimativas
Stereotaxis earnings matched, revenue fell short of estimates
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates